Komvos is developing activities in the field of Health Biotechnology and the development of this sector in Greece. The initiative is being implemented in collaboration with the ARISTEiA Institute of the USA.
The recent conference on biotechnology synergy structures, held under the initiative of Komvos in collaboration with the ARISTEiA Institute of the USA, highlighted some critical issues regarding the development of research and innovation in Greece.
Watch the video of the discussion here. Read more about the conference’s summary.
Biotechnology and health sciences are sectors at the forefront of our time. Along with Artificial Intelligence and the Internet, they are shaping the 21st century.
Kombos, in collaboration with the ARISTEiA Institute, has taken the initiative to explore the conditions that will contribute to positioning Greece as one of the leading global forces in the field of Research and Health Biotechnology.
Read more here about this initiative.
For an industry growing at an annual rate of 13%, and expected to create an economic impact of around 1.2 trillion dollars by 2030, it is only natural that we focus on the funding tools for development.
Read more about what was discussed regarding funding tools in the Biotechnology sector at the panel moderated by Harris Antoniou. Click here!
Scientists from the diaspora and Greece can collaborate on global platforms to create the stimuli that will activate entrepreneurs and investors. There are many success stories, and the Greek production sector is finding its rhythm.
Read more about the discussion moderated by Dr. Sotirios Stergiopoulos here!
Mike Romanos (Associate Dean for Enterprise, Faculty of Medicine, Imperial College & Co-Founder and Interim CEO, NK:IO Ltd, UK), the keynote speaker of the conference on Synergy Structures-Health-Biotechnology-Economics, discussed the opportunities and possibilities offered by research and innovation in the field of Life Sciences.
Development is based on innovation, and innovation on research. All major and technologically advanced countries have realized this, which is why they invest enormous amounts of capital, in the billions of dollars, in research.
Greece has the human capital to support research. What steps must be taken for Greece to claim the role it deserves, based on its comparative advantages?
Read more here and watch the video of the introductory session for the 2nd Conference on Synergy Structures-Health-Biotechnology-Economics.
A short video featuring a small portion of the key points discussed during the first conference on Synergy Structures-Health-Biotechnology-Economics. We have selected some of the main points discussed to make it easier for you to connect with the 2nd conference.
Main points from the first conference on Synergy Structures – video – KOMVOS (komvos-node.org)
Synergy Structures-Health-Biotechnology-Economics. 2nd part: We agree that Greece can. Next Steps?
In the second conference, we explore the steps that need to be taken for Greece to leverage its strategic advantages in order to achieve the goal of becoming a leading force in the field of Biotechnology and Health Sciences, in collaboration with Greeks abroad. Read more here!
Greece can be the Biotechnology Hub for Europe in the next 10 years!
This is the optimistic message we received from the biotechnology session at the 1st Annual conference of Komvos.
Read more here. Watch the related video on the Komvos YouTube channel!
1st Conference of Komvos on Synergy Structures-Health-Biotechnology-Economics
The first part of the discussion was held with the participation of Professor John Ioannidis (Stanford University), Kyriaki Bakirtzi (ELPEN Pharmaceutical Industry), Georgios Xirogiannis (Hellenic Association of Enterprises and Industries), and Harrietta Eleftherohorinou (IQVIA, Innovation Ventures), focusing on synergy structures as agents of scientific development.
The discussion was moderated by George Nounesis (NCSR Demokritos and Board Member of Komvos).
1st Conference of Komvos on Synergy Structures-Health-Biotechnology-Economics.
Under the sub-title “Synergy Structures as Investment Attractors,” the second part of the discussion continued, moderated by Faye Makantasi (DiNEOssis Research and Analysis Organization and corporate member of Komvos).
The discussion featured the following participants (alphabetically): Nikos Vettas (Foundation for Economic and Industrial Research, Athens University of Economics and Business, and corporate member of Komvos), Aris Doxiadis (National Council for Research, Technology, Innovation, and Big Pi Ventures), Pavlos Efthimiou (Hellenic Federation of Enterprises & Athens Medical Center), Alexandra Holi (Epagon Venture Capital).
Can we create the Mount Athos of science in Greece?
A wish, hope, or prospect?
See the conclusions of the 1st Biotechnology Conference on Synergy Structures-Health-Biotechnology-Economics.
The sponsor of the Synergy Structures-Health-Biotechnology-Economics Seminars is the pharmaceutical company DEMO ABEE.
Komvos’ Grand Sponsor is Piraeus Bank, which plays a crucial role in realizing its vision.
The featured photo on this page is royalty-free under certain conditions: <a href=”https://www.vecteezy.com/free-photos/bio-technology”>Bio Technology Stock photos by Vecteezy</a>